UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
September 1, 2005
CHEMED CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 1-8351 31-0791746
(State or other (Commission File Number) (I.R.S. Employer
jurisdiction of Identification
incorporation) Number)
2600 Chemed Center, 255 East 5th Street, Cincinnati, OH 45202
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(513) 762-6900
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2 below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
230.425)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange
Act (17 CFR 230.425)
[_] Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange
Act (17 CFR 230.425)
Page 1 of 2
Item 8.01 Other Events
On September 1, 2005, Chemed Corporation (the "Company") sent notice to the
New York Stock Exchange (the "NYSE") that the Company had inadvertently omitted
to state in the proxy statement for the 2005 Annual Meeting to Stockholders (the
"2005 Proxy Statement") that its Policies on Business Ethics and Corporate
Governance Principles were available on its website under Corporate Governance -
Governance Documents (www.chemed.com) and that a printed copy may also be
obtained upon request from the Company's Corporate Secretary at 2600 Chemed
Center, 255 E. Fifth Street, Cincinnati OH 45202-4726. Section 303A.10 of the
NYSE Listed Company Manual (the "Manual") requires these statements be included
in the annual proxy statement. A copy of these documents was incorporated in the
Company's 2004 Form 10-K Annual Report as Exhibit 14 and a copy of these
documents is and was then available on the Company's website.
In addition, Section 303A.03 of the Manual requires the Company to either
identify a non-management director who has been chosen to preside over executive
sessions of the non-management directors, or disclose the procedure by which
such a presiding director is selected. While Section 3 of the Company's
Corporate Governance Principles sets forth this procedure, a copy of which
procedure is, and has been available on the Company's website, a description of
this procedure was inadvertently omitted from the 2005 Proxy Statement. Section
3 of the Company's Corporate Governance Principles provides, in part:
The board of directors has five scheduled meetings a year at which it
reviews and discusses reports by management on the performance of the
corporation and its operating subsidiaries, its plans and prospects, as
well as immediate issues facing the corporation. The board meets during
each of its meetings in executive sessions, without employees or
non-independent directors present. Such sessions are presided over by
various independent directors.
While the Company does not believe that either of the items above are
material, the Company is correcting its inadvertent non-compliance by filing
this Current Report on Form 8-K with the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
CHEMED CORPORATION
Dated: September 2, 2005 By: /s/ Arthur V. Tucker, Jr.
------------------ --------------------------
Arthur V. Tucker, Jr.
Vice President and Controller
Page 2 of 2